tiprankstipranks
Trending News
More News >
Frontage Holdings Corp. (HK:1521)
:1521
Hong Kong Market

Compare Frontage Holdings Corp. (1521) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Frontage Holdings Corp.
HK$1.03
HK$2.02B
67.35
-35.29%
Genscript Biotech
HK$14.33
$31.17B
53.26%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.16
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Simcere Pharmaceutical Group Limited
HK$12.15
HK$31.54B
31.48
81.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.48
HK$5.90B
153.40
12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1521
Frontage Holdings Corp.
0.99
-0.48
-32.65%
HK:1548
Genscript Biotech
14.33
5.33
59.22%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.68
140.08%
HK:2096
Simcere Pharmaceutical Group Limited
12.15
5.73
89.25%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
44.50
197.78%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.48
0.79
9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts